glp-1 side effects Ozempic and Drugs: Risk of Severe Glucagon-like Receptor-1 agonists for obesity:
Description
Emerging research on GLP-1 medications covers fatty liver, kidney disease, sleep apnoea, PCOS, and neurodegeneration
Exception: If your health would be seriously harmed by waiting, you can file for IMR immediately
They get meaningful results with minimal side effects, and more importantly, theyre building sustainable skills rather than just depending on medication
The DURATION-1 and DURATION-5 clinical trials, which directly compared exenatide BID (Byetta) to exenatide QW (Bydureon), reported better HbA1c level reduction for Bydureon [119, 120]
